The General Hospital Corporation

Rhode Island Hospital

Rhode Island Hospital, a Lifespan-partner

Universidade Estadual Paulista/unesp

Helen Burgwyn Fuchs

Eleftherios Mylonakis

Frederick M Ausubel

Wooseong Kim

Juliana Campos Junqueira

Raj Mohan Raja Muthiah

The present application provides that synthetic retinoid compounds are useful in methods of treating bacterial infections, such as a bacterial infection caused by, methicillin-resistant(MRSA), vancomycin-resistant(VRSA),, and. The present application also provides a tricyclic fluoroquinolone compound, Z3060, useful in methods of treating bacterial infections, such as a bacterial infection caused by, methicillin-resistant(MRSA), vancomycin-resistant(VRSA),. spp.,, and. Also provided herein is a gold compound, auranofin, useful in treating bacterial and fungal infections, such as a fungal infection caused by, and

Antibacterial and antifungal compounds

The invention provides a method and bacterial compositions for reducing or preventing an infection of a bodily tissue by a fungal microorganism by contacting the tissue with a composition comprising a purifiedbacterium.

Probiotic bacteria-directed prevention or treatment of fungal infection

Growing community of inventors

Quincy, MA, United States of America

Helen Burgwyn Fuchs